Ophthalmology, Retina Specialist · Gainesville, FL
NPI
1265641534
Since 2007
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4340 W Newberry Rd Ste 202
Gainesville, FL, 32607
Phone (352) 371-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
40,983 services
Medicare patients, 2024
740
Average age 79
Drug cost, 2024
$244K
467 prescriptions
Company payments, 2025
$227
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Parrott was code J2777 (injection, faricimab-svoa, 0.1 mg), 18,780 times for 55 patients. In total Michael B Parrott billed 40,983 services in 33 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 18,780 | 55 | $27.41 | $515K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 7,200 | 76 | $117.01 | $842K |
| J0178 Injection, aflibercept, 1 mg | Office | 4,096 | 305 | $659.17 | $2.7M |
| 92134 Computerized Ophthalmic Imaging | Office | 3,102 | 729 | $29.76 | $92K |
| 67028 Intravitreal Injection | Office | 2,910 | 446 | $95.17 | $277K |
| 92014 Ophthalmological E&M | Office | 1,222 | 641 | $89.55 | $109K |
| 92012 Ophthalmological E&M | Office | 1,154 | 425 | $66.10 | $76K |
| 92250 Angiography | Office | 591 | 543 | $27.11 | $16K |
| Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 460 | 32 | $131.12 | $60K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 405 | 19 | $132.34 | $54K |
| J7999 Compounded drug, not otherwise classified | Office | 258 | 46 | $65.39 | $17K |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 231 | 12 | $160.88 | $37K |
| 92004 Ophthalmological E&M | Office | 121 | 121 | $98.39 | $12K |
| 92235 Angiography | Office | 19 | 19 | $129.38 | $2,458 |
| 67042 Vitrectomy - Mechanical | Facility | 14 | 11 | $920.01 | $13K |
By year: 2022 $3.8M for 14,922 services; 2023 $4.4M for 23,948 services; 2024 $4.9M for 40,983 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Parrott prescribed most often to Medicare patients was Prednisolone Acetate, with 126 prescriptions and refills. In total Michael B Parrott wrote 467 Medicare prescriptions that cost $244K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 126 | 236 | 52 | $8,284 |
| Syfovre Pegcetacoplan/Pf | 74 | 87 | 15 | $199K |
| Moxifloxacin Moxifloxacin Hcl | 56 | 57 | 31 | $1,495 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 52 | 104 | 13 | $697 |
| Latanoprost Generic | 40 | 51 | Under 11 | $298 |
| Atropine Sulfate Generic | 17 | 26 | Under 11 | $610 |
| Timolol Maleate Generic | 15 | 32 | Under 11 | $136 |
| Ketorolac Tromethamine Generic | 13 | 25 | Under 11 | $307 |
| Prolensa Bromfenac Sodium | 11 | 11 | Under 11 | $3,953 |
Brand drugs: 242 claims; generic drugs: 225 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Parrott $227 ($227 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genentech USA, Inc. with $104.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.